Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Regulating tumor suppressor genes: post-translational modifications
Ling Chen, Shuang Liu, Yongguang Tao
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 324

Showing 26-50 of 324 citing articles:

p53: From Fundamental Biology to Clinical Applications in Cancer
Maurizio Capuozzo, Mariachiara Santorsola, Marco Bocchetti, et al.
Biology (2022) Vol. 11, Iss. 9, pp. 1325-1325
Open Access | Times Cited: 40
PCDHB14 promotes ferroptosis and is a novel tumor suppressor in hepatocellular carcinoma
Yating Liu, Lianlian Ouyang, Chao Mao, et al.
Oncogene (2022) Vol. 41, Iss. 27, pp. 3570-3583
Closed Access | Times Cited: 39
GINS4 suppresses ferroptosis by antagonizing p53 acetylation with Snail
Ling Chen, Qidong Cai, Rui Yang, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 15
Open Access | Times Cited: 32
Advancement in Biopolymer Assisted Cancer Theranostics
Tanima Bhattacharya, Subham Preetam, Basab Ghosh, et al.
ACS Applied Bio Materials (2023) Vol. 6, Iss. 10, pp. 3959-3983
Open Access | Times Cited: 29
Acetylation Targeting Chimera Enables Acetylation of the Tumor Suppressor p53
Md Kabir, Ning Sun, Xiao Hu, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 27, pp. 14932-14944
Closed Access | Times Cited: 26
Biological effects and mechanisms of fisetin in cancer: a promising anti-cancer agent
Chenhui Zhou, Yi Huang, Sheng Nie, et al.
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 25
TRIM21‐Promoted FSP1 Plasma Membrane Translocation Confers Ferroptosis Resistance in Human Cancers
Jun Gong, Yuhui Liu, Wenjia Wang, et al.
Advanced Science (2023) Vol. 10, Iss. 29
Open Access | Times Cited: 23
GPR162 activates STING dependent DNA damage pathway as a novel tumor suppressor and radiation sensitizer
Yao Long, Jiaxing Guo, Jielin Chen, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 22
Multiple aspects of matrix stiffness in cancer progression
Alessandro Mancini, Maria Teresa Gentile, Francesca Pentimalli, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 11
Lactylome analyses suggest systematic lysine-lactylated substrates in oral squamous cell carcinoma under normoxia and hypoxia
Song Fan, Chen Hou, Sen Zhao, et al.
Cellular Signalling (2024) Vol. 120, pp. 111228-111228
Open Access | Times Cited: 9
Icaritin activates p53 and inhibits aerobic glycolysis in liver cancer cells
Xiangyang Zhou, Di Wu, Tian Mi, et al.
Chemico-Biological Interactions (2024) Vol. 392, pp. 110926-110926
Closed Access | Times Cited: 8
The molecular code of kidney cancer: A path of discovery for gene mutation and precision therapy
Deqian Xie, Guandu Li, Zhonghua Zheng, et al.
Molecular Aspects of Medicine (2025) Vol. 101, pp. 101335-101335
Open Access | Times Cited: 1
PRMT5-mediated arginine methylation stabilizes GPX4 to suppress ferroptosis in cancer
Yizeng Fan, Yuzhao Wang, Weichao Dan, et al.
Nature Cell Biology (2025)
Closed Access | Times Cited: 1
Palbociclib in combination with letrozole in patients with estrogen receptor–positive, human epidermal growth factor receptor 2–negative advanced breast cancer: PALOMA-2 subgroup analysis of Japanese patients
Hirofumi Mukai, Chikako Shimizu, Norikazu Masuda, et al.
International Journal of Clinical Oncology (2018) Vol. 24, Iss. 3, pp. 274-287
Open Access | Times Cited: 62
Regulation of the p53 Family Proteins by the Ubiquitin Proteasomal Pathway
Scott Bang, Sandeep Kaur, Manabu Kurokawa
International Journal of Molecular Sciences (2019) Vol. 21, Iss. 1, pp. 261-261
Open Access | Times Cited: 56
Therapeutic Potential of Targeting the SUMO Pathway in Cancer
Antti Kukkula, Veera K. Ojala, Lourdes M. Mendez, et al.
Cancers (2021) Vol. 13, Iss. 17, pp. 4402-4402
Open Access | Times Cited: 47
A Bibliometric Analysis Based on Web of Science: Current Perspectives and Potential Trends of SMAD7 in Oncology
Xueying Huang, Zhiying Yang, Jinning Zhang, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 9
Open Access | Times Cited: 35
Role of Immune Cells and Receptors in Cancer Treatment: An Immunotherapeutic Approach
Anirban Goutam Mukherjee, Uddesh Ramesh Wanjari, Arunraj Namachivayam, et al.
Vaccines (2022) Vol. 10, Iss. 9, pp. 1493-1493
Open Access | Times Cited: 35
Post-Translational Modifications of BRD4: Therapeutic Targets for Tumor
Na Liu, Rui Ling, Xiang Tang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 30
Ferroptosis: an important player in the inflammatory response in diabetic nephropathy
Jialing Li, Luxin Li, Zhen Zhang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 21
p53 deacetylation alleviates calcium oxalate deposition-induced renal fibrosis by inhibiting ferroptosis
Zehua Ye, Yuqi Xia, Lei Li, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114925-114925
Open Access | Times Cited: 20
Amomum subulatum: A treasure trove of anti-cancer compounds targeting TP53 protein using in vitro and in silico techniques
Sadaqat Ali, Asifa Noreen, Adeem Qamar, et al.
Frontiers in Chemistry (2023) Vol. 11
Open Access | Times Cited: 17
The Functional Roles of ISG15/ISGylation in Cancer
Yuan Yin, Hai Qin, Huilong Li, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1337-1337
Open Access | Times Cited: 16
Liquid-liquid phase separation in DNA double-strand breaks repair
Yunlong Wang, Wan-Wen Zhao, Jie Shi, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 11
Open Access | Times Cited: 16
Prebiotic proanthocyanidins inhibit bile reflux-induced esophageal adenocarcinoma through reshaping the gut microbiome and esophageal metabolome
Katherine M. Weh, Connor L. Howard, Yun Zhang, et al.
JCI Insight (2024)
Open Access | Times Cited: 7

Scroll to top